(Q34478105)

English

Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 August 2017

Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis (English)

1 reference

Europe PubMed Central

2 August 2017

corrigendum / erratum

Erratum to: Overall survival differences between patients with inflammatory and noninflammatory breast cancer presenting with distant metastasis at diagnosis

0 references

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26017070%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26017070%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Wendy A Woodward

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26017070%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Mariana Chavez-MacGregor

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26017070%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Gildy V Babiera

13

object named as

Gildy Babiera

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26017070%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

author name string

Takahiro Kogawa

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26017070%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Diane D Liu

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26017070%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Hiroko Masuda

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26017070%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Randa El-Zein

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26017070%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Ricardo H Alvarez

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26017070%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Banu Arun

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26017070%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Anthony Lucci

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26017070%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Savitri Krishnamurthy

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26017070%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Thomas A Buchholz

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26017070%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Vicente Valero

15

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26017070%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Naoto T Ueno

16

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26017070%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

language of work or name

0 references

publication date

29 May 2015

1 reference

Europe PubMed Central

2 August 2017

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26017070%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

152

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26017070%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26017070%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

407-416

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26017070%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

https://scigraph.springernature.com/pub.10.1007/s10549-015-3436-x

0 references

Comparison of molecular subtype distribution in triple-negative inflammatory and non-inflammatory breast cancers

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4492876

6 July 2018

Outcomes After Multidisciplinary Treatment of Inflammatory Breast Cancer in the Era of Neoadjuvant HER2-directed Therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4492876

6 July 2018

Gene pathways associated with prognosis and chemotherapy sensitivity in molecular subtypes of breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4492876

6 July 2018

Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4492876

6 July 2018

International expert panel on inflammatory breast cancer: consensus statement for standardized diagnosis and treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4492876

6 July 2018

Inflammatory breast cancer--The Royal Marsden Hospital experience: a review of 155 patients treated from 1990 to 2007.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4492876

6 July 2018

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4492876

6 July 2018

Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4492876

6 July 2018

Third consensus on medical treatment of metastatic breast cancer.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4492876

6 July 2018

Does resection of an intact breast primary improve survival in metastatic breast cancer?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4492876

6 July 2018

Epidemiology of inflammatory breast cancer (IBC).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4492876

6 July 2018

Extending survival with chemotherapy in metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4492876

6 July 2018

Trends in inflammatory breast carcinoma incidence and survival: the surveillance, epidemiology, and end results program at the National Cancer Institute

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4492876

6 July 2018

Population-based statistics for women diagnosed with inflammatory breast cancer (United States).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4492876

6 July 2018

The role of chemotherapy for metastatic breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4492876

6 July 2018

Beyond palliative mastectomy in inflammatory breast cancer--a reassessment of margin status

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4492876

6 July 2018

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4492876

6 July 2018

Long-term results of a combined modality approach in treating inflammatory carcinoma of the breast

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4492876

6 July 2018

Inflammatory breast cancer: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4492876

6 July 2018

Long-term follow-up for locally advanced and inflammatory breast cancer patients treated with multimodality therapy

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3436-X

21 January 2018

The performance of different propensity-score methods for estimating relative risks

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3436-X

21 January 2018

Breast cancer with synchronous metastases: trends in survival during a 14-year period

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3436-X

21 January 2018

Effect of visceral metastases on the efficacy and safety of everolimus in postmenopausal women with advanced breast cancer: subgroup analysis from the BOLERO-2 study.

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3436-X

21 January 2018

Surgery of the primary tumor in metastatic breast cancer: closing the barn door after the horse has bolted?

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3436-X

21 January 2018

Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4492876

27 October 2018

https://api.crossref.org/works/10.1007%2FS10549-015-3436-X

21 January 2018

Breast Cancer Metastasis: Challenges and Opportunities

1 reference

https://api.crossref.org/works/10.1007%2FS10549-015-3436-X

21 January 2018

A note on quantifying follow-up in studies of failure time

1 reference

https://pubmed.ncbi.nlm.nih.gov/26017070

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evolving treatment strategies for inflammatory breast cancer: a population-based survival analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/26017070

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Trends for Inflammatory Breast Cancer: Is Survival Improving?

1 reference

https://pubmed.ncbi.nlm.nih.gov/26017070

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/26017070

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differences in survival among women with stage III inflammatory and noninflammatory locally advanced breast cancer appear early

1 reference

https://pubmed.ncbi.nlm.nih.gov/26017070

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifying factors that impact survival among women with inflammatory breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/26017070

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical significance of HER-2/neu oncogene amplification in primary breast cancer. The South Australian Breast Cancer Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/26017070

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S10549-015-3436-X

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26017070%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26017070%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26017070%20AND%20SRC:MED&resulttype=core&format=json

12 June 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34478105&oldid=2121315092"